If the lack of information regarding canines is because PAA is focusing on a human clinical trial, then I'm ok with it. As I've been saying for a couple of years - this stock won't shoot up until the scattergun approach is left behind in favour of a methodical and reasoned approach.
If the lack of information regarding canines is because PAA is...
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.010(6.06%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.8¢ | $65.70K | 380.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31853 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 336091 | 5 |
View Market Depth
| Last trade - 11.36am 16/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |